MS patients revealed NOS2 expression in the chronic active plaques in diverse cell types, including microglia/macrophages (MG/Mφ), ependymal cells, inflammatory cells, and to a certain extent astrocytes [6]. The gene discussed is NOS2; the disease is myeloid sarcoma.